Twist Bioscience logo

Twist Bioscience

TWST | NASDAQ
Chart Builder DCF Calculator
$105.04
-$6.56 (-5.88%)
At close: Nov 16, 2026, 4:00 PM ET
$105.00
-$0.04 (-0.04%)
After-hours: Nov 16, 2026, 7:55 PM ET
-5.88%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
48
-1.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #330/1021 (Top 32%)

Key Statistics

Market Data

Market Cap $6.92B
1D Range
101.05 106.28
52W Range
25.45 205.00

Valuation (TTM)

PE -50.50
PB 7.79
EV/EBITDA -49.52

Valuation (NTM)

Forward PE N/A
Forward PEG 1.50
Price Target $137.00
Loading financial charts...

Profile

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthes...

Sector Healthcare
Industry Biotechnology
Employees 979
IPO Date Oct 31, 2018
Fiscal Year October - September

Latest News

Twist Bioscience: Long-Term 'Buy' On AI Discovery For Biotech

13 hours ago · seekingalpha.com

Twist Bioscience: Long-Term 'Buy' On AI Discovery For Biotech
Twist Bioscience Q4 Earnings Call Highlights

4 days ago · marketbeat.com

Twist Bioscience Q4 Earnings Call Highlights
Twist Bioscience: 3 Key Takeaways for Long-Term Investors

4 days ago · fool.com

Twist Bioscience: 3 Key Takeaways for Long-Term Investors
Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript

4 days ago · seekingalpha.com

Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript
Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates

4 days ago · zacks.com

Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results

4 days ago · businesswire.com

Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

5 days ago · businesswire.com

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience to Present at Upcoming Investor Conferences

8 days ago · businesswire.com

Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bioscience Stock Hits New High, Then Retreats: What's Happening?

2 months ago · benzinga.com

Twist Bioscience Stock Hits New High, Then Retreats: What's Happening?
Why Twist Bioscience Stock Skyrocketed This Week

2 months ago · fool.com

Why Twist Bioscience Stock Skyrocketed This Week

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.32
Beat +17.33%
REV
$126.64M
Beat +2.51%
Next Earnings
Feb 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
9
Consensus
Buy
Price Target
$137.00
Upside
+30.43%
Buy (7)
Hold (1)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.